135 related articles for article (PubMed ID: 16835330)
21. A comparison between p53 accumulation determined by immunohistochemistry and TP53 mutations as prognostic variables in tumours from breast cancer patients.
Alsner J; Jensen V; Kyndi M; Offersen BV; Vu P; Børresen-Dale AL; Overgaard J
Acta Oncol; 2008; 47(4):600-7. PubMed ID: 18465328
[TBL] [Abstract][Full Text] [Related]
22. Aneuploidy and overexpression of Ki67 and p53 as markers for neoplastic progression in Barrett's esophagus: a case-control study.
Sikkema M; Kerkhof M; Steyerberg EW; Kusters JG; van Strien PM; Looman CW; van Dekken H; Siersema PD; Kuipers EJ
Am J Gastroenterol; 2009 Nov; 104(11):2673-80. PubMed ID: 19638963
[TBL] [Abstract][Full Text] [Related]
23. Mutational analysis of p53 in human tumors: direct DNA sequencing and SSCP.
Erster S; Slade N; Moll UM
Methods Mol Biol; 2003; 234():219-30. PubMed ID: 12824535
[TBL] [Abstract][Full Text] [Related]
24. Serum antibodies against p53 in relation to cancer risk and prognosis in breast cancer: a population-based epidemiological study.
Lenner P; Wiklund F; Emdin SO; Arnerlöv C; Eklund C; Hallmans G; Zentgraf H; Dillner J
Br J Cancer; 1999 Feb; 79(5-6):927-32. PubMed ID: 10070892
[TBL] [Abstract][Full Text] [Related]
25. Breast cancer, serum antioxidant vitamins, and p53 protein overexpression.
Kim MK; Park YG; Gong G; Ahn SH
Nutr Cancer; 2002; 43(2):159-66. PubMed ID: 12588696
[TBL] [Abstract][Full Text] [Related]
26. Interest of investigating p53 status in breast cancer by four different methods.
Thirion A; Rouanet P; Thezenas S; Detournay D; Grenier J; Lopez-Crapez E
Oncol Rep; 2002; 9(6):1167-72. PubMed ID: 12375013
[TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical detection of c-erbB-2 and p53 in benign breast disease and breast cancer risk.
Rohan TE; Hartwick W; Miller AB; Kandel RA
J Natl Cancer Inst; 1998 Sep; 90(17):1262-9. PubMed ID: 9731732
[TBL] [Abstract][Full Text] [Related]
28. The effect of the I1307K APC polymorphism on the clinicopathological features and natural history of breast cancer.
Yuan ZQ; Bégin LR; Wong N; Brunet JS; Trifiro M; Gordon PH; Pinsky L; Foulkes WD
Br J Cancer; 1999 Nov; 81(5):850-4. PubMed ID: 10555757
[TBL] [Abstract][Full Text] [Related]
29. Plasma isoflavones and fibrocystic breast conditions and breast cancer among women in Shanghai, China.
Lampe JW; Nishino Y; Ray RM; Wu C; Li W; Lin MG; Gao DL; Hu Y; Shannon J; Stalsberg H; Porter PL; Frankenfeld CL; Wähälä K; Thomas DB
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2579-86. PubMed ID: 18086761
[TBL] [Abstract][Full Text] [Related]
30. Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study.
McCullough ML; Stevens VL; Diver WR; Feigelson HS; Rodriguez C; Bostick RM; Thun MJ; Calle EE
Breast Cancer Res; 2007; 9(1):R9. PubMed ID: 17244366
[TBL] [Abstract][Full Text] [Related]
31. Age-related lobular involution and risk of breast cancer.
Milanese TR; Hartmann LC; Sellers TA; Frost MH; Vierkant RA; Maloney SD; Pankratz VS; Degnim AC; Vachon CM; Reynolds CA; Thompson RA; Melton LJ; Goode EL; Visscher DW
J Natl Cancer Inst; 2006 Nov; 98(22):1600-7. PubMed ID: 17105983
[TBL] [Abstract][Full Text] [Related]
32. Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses' Health Study.
Collins LC; Baer HJ; Tamimi RM; Connolly JL; Colditz GA; Schnitt SJ
Cancer; 2007 Jan; 109(2):180-7. PubMed ID: 17154175
[TBL] [Abstract][Full Text] [Related]
33. Increased breast cancer risk after radiotherapy for acne among women with skin cancer.
El-Gamal H; Bennett RG
J Am Acad Dermatol; 2006 Dec; 55(6):981-9. PubMed ID: 17097395
[TBL] [Abstract][Full Text] [Related]
34. An intronic variant in the TP53 gene in a Brazilian woman with breast cancer.
Lacerda LL; Serrano SV; Mathes A; Rey JA; Bello MJ; Casartelli C
Cancer Genet Cytogenet; 2005 Jul; 160(2):160-3. PubMed ID: 15993272
[TBL] [Abstract][Full Text] [Related]
35. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
[TBL] [Abstract][Full Text] [Related]
36. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
[TBL] [Abstract][Full Text] [Related]
37. Folate intake, methylenetetrahydrofolate reductase polymorphisms, and breast cancer risk in women from the Malmö Diet and Cancer cohort.
Ericson U; Sonestedt E; Ivarsson MI; Gullberg B; Carlson J; Olsson H; Wirfält E
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1101-10. PubMed ID: 19336565
[TBL] [Abstract][Full Text] [Related]
38. Mutation screening of the BRCA1 gene in sporadic breast cancer in southern Chinese populations.
Haitian Z; Yunfei L; Jian Z; Jian L; Qinghua L; Fuqiang W
Breast; 2008 Dec; 17(6):563-7. PubMed ID: 18835712
[TBL] [Abstract][Full Text] [Related]
39. p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never-smokers.
Ji X; Neumann AS; Sturgis EM; Adler-Storthz K; Dahlstrom KR; Schiller JT; Wei Q; Li G
Carcinogenesis; 2008 Apr; 29(4):875-9. PubMed ID: 18258602
[TBL] [Abstract][Full Text] [Related]
40. DNA methylation in benign breast epithelium in relation to age and breast cancer risk.
Euhus DM; Bu D; Milchgrub S; Xie XJ; Bian A; Leitch AM; Lewis CM
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1051-9. PubMed ID: 18483325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
